Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Norway

European Innovation Council · Running

iScan Automated retinal scans for early detection of diabetic eye diseases through use of artificial intelligence

Coordinator
Oivi AS, Norway
Runs
1 January 2023 to 31 December 2024
Status
Running
EU funding
€2.5m
Total cost
€3.6m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190126744

What the project is doing

In the project's own words, from its summary on CORDIS.

Oivi provides affordable eye care for all and prevent unnecessary blindness by providing a low-cost camera for retinal (fundus) photography, with fully automated image capture and diagnostics. Oivi is a point-of-care device for eye screening of diabetic retinopathy (DR). DR affects >160 M people worldwide and is the most common cause of blindness among working-age adults. Yet, early detection can successfully prevent vision-loss in 95% of the cases.

Current solutions for DR screening are expensive and require extensive training that limits accessibility to patients, especially in developing countries. Oivi is a unique combination of automated, easy-to-use, low-cost and integrated Machine Learning/Artificial Intelligence solutions (for image capturing and DR diagnostic) in a highly portable design. Within the iScan project, we want to mature the device and its diagnostic functionalities, to clinically validate our solution and to assure regulatory approvals.

Topics

Who is involved

OrganisationCityCountryRole
Oivi ASOsloNorwayCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI